Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

EBITDA Summary of Medtecs International Corporation Limited

  • Medtecs International Corporation Limited's latest annual EBITDA in 2023 was -14.56 Million USD , up 37.02% from previous year.
  • Medtecs International Corporation Limited's latest quarterly EBITDA in 2024 Q2 was -3.35 Million USD , up 79.49% from previous quarter.
  • Medtecs International Corporation Limited reported an annual EBITDA of -23.43 Million USD in 2022, down -197.14% from previous year.
  • Medtecs International Corporation Limited reported an annual EBITDA of 24.37 Million USD in 2021, down -83.15% from previous year.
  • Medtecs International Corporation Limited reported a quarterly EBITDA of N/A for 2023 FY, up 37.02% from previous quarter.
  • Medtecs International Corporation Limited reported a quarterly EBITDA of -4.41 Million USD for 2023 Q2, up 83.9% from previous quarter.

Annual EBITDA Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual EBITDA of Medtecs International Corporation Limited (2023 - 2009)

Year EBITDA EBITDA Growth
2023 -14.56 Million USD 37.02%
2022 -23.43 Million USD -197.14%
2021 24.37 Million USD -83.15%
2020 144.64 Million USD 1405.62%
2019 9.6 Million USD 21.48%
2018 5.05 Million USD 54.39%
2017 5.19 Million USD -12.4%
2016 5.29 Million USD -12.43%
2015 6.48 Million USD -4.29%
2014 5.33 Million USD 4.35%
2013 5.78 Million USD -13.86%
2012 7.69 Million USD -19.14%
2011 7.56 Million USD 54.48%
2010 6.21 Million USD -2.48%
2009 6.37 Million USD 0.0%

Peer EBITDA Comparison of Medtecs International Corporation Limited

Name EBITDA EBITDA Difference
Nang Kuang Pharmaceutical Co., Ltd. 402.69 Million TWD 103.617%
Maxigen Biotech Inc. 177.09 Million TWD 108.224%
SciVision Biotech Inc. 281.34 Million TWD 105.177%
Bionime Corporation 179.78 Million TWD 108.101%
Pegavision Corporation 2.91 Billion TWD 100.499%
Visco Vision Inc. 733.58 Million TWD 101.985%